Price target upside
Actuate Therapeutics, Inc. - Common stock Price Target Upside or Downside
ACTU price target upside based on the current price and analyst average.
Direct answer
Actuate Therapeutics, Inc. - Common stock's analyst target implies +790.8%.
The average target is $9.98 compared with a recorded current price of $1.12.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 4, 2026.
Verified data
- Current price
- $1.12
- Average price target
- $9.98
- High price target
- $14.91
- Low price target
- $5.00
- Target upside
- +790.8%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- August 4, 2026
- Valid through
- August 11, 2026